Ulash S. Kench
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ulash S. Kench has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Pavel Spirin
Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991 Moscow, Russia
3 shared publications - Susanna Sergeevna Sologova
Sechenov First Moscow State Medical University (Sechenov University)
3 shared publications - Vladimir Sergeyevich Prassolov
Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991 Moscow, Russia
2 shared publications - Elena A. Smolyarchuk
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
1 shared publication
Latest Publications
- Open Access
- 11 October 2024
- Published by MDPI AG in Pharmaceuticals
- Vol. 17 (10) , 1355
Pharmaceutical Agents for Targeting Autophagy and Their Applications in Clinics
Autophagy is the process by which damaged regions of the cytoplasm and intracellular pathogens are degraded. This mechanism often serves an adaptive role in cells, enhancing their survival. It plays a direct or indirect role in the development of various pathological conditions within the body. This phenomenon is common in various malignant diseases, where autophagy is associated with the resistance of transformed cells to chemotherapy. Conversely, abnormal activation of autophagy can trigger cell death, a process often seen in neurodegenerative conditions. Given that dysregulation of autophagy is associated with the progression of numerous pathological conditions, this is of significant interest to the developers of drugs that can effectively modulate autophagy for both basic research and clinical applications. Here, we provide a brief description of the mechanism of macroautophagy, the most prevalent form of autophagy identified in humans. We also discuss the clinical potential of drugs that can modulate autophagy, highlighting their use in combating diseases associated with direct or indirect dysregulation of this essential process.
- 11 October 2024
- Published by MDPI AG in Pharmaceuticals
- Vol. 17 (10) , 1355
Open AccessPharmaceutical Agents for Targeting Autophagy and Their Applications in Clinics
Autophagy is the process by which damaged regions of the cytoplasm and intracellular pathogens are degraded. This mechanism often serves an adaptive role in cells, enhancing their survival. It plays a direct or indirect role in the development of various pathological conditions within the body. This phenomenon is common in various malignant diseases, where autophagy is associated with the resistance of transformed cells to chemotherapy. Conversely, abnormal activation of autophagy can trigger cell death, a process often seen in neurodegenerative conditions. Given that dysregulation of autophagy is associated with the progression of numerous pathological conditions, this is of significant interest to the developers of drugs that can effectively modulate autophagy for both basic research and clinical applications. Here, we provide a brief description of the mechanism of macroautophagy, the most prevalent form of autophagy identified in humans. We also discuss the clinical potential of drugs that can modulate autophagy, highlighting their use in combating diseases associated with direct or indirect dysregulation of this essential process.
- Open Access
- 30 October 2023
- Published by Acta Naturae Ltd in Acta Naturae
- Vol. 15 (3) , 37-49
The Role of Autophagy in the Development of Pathological Conditions of the Body
Autophagy is the process of lysosomal elimination of the cell organelles, cytoplasmic sites, and pathogenic microorganisms that enter the cell. This process is associated with both cell death regulation and an increase in cell survival chances. Autophagy is involved in the development of various diseases (Crohn disease, cancer, atherosclerosis, etc.). For these reasons, it is of significant interest to establish the molecular targets involved in autophagy regulation and the factors that mediate its participation in pathogenesis. The review describes the potential molecular mechanisms involved in the regulation of autophagy, its contribution to the vital cell activity in a healthy organism, and pathologies.
- 30 October 2023
- Published by Acta Naturae Ltd in Acta Naturae
- Vol. 15 (3) , 37-49
Open AccessThe Role of Autophagy in the Development of Pathological Conditions of the Body
Autophagy is the process of lysosomal elimination of the cell organelles, cytoplasmic sites, and pathogenic microorganisms that enter the cell. This process is associated with both cell death regulation and an increase in cell survival chances. Autophagy is involved in the development of various diseases (Crohn disease, cancer, atherosclerosis, etc.). For these reasons, it is of significant interest to establish the molecular targets involved in autophagy regulation and the factors that mediate its participation in pathogenesis. The review describes the potential molecular mechanisms involved in the regulation of autophagy, its contribution to the vital cell activity in a healthy organism, and pathologies.
- 1 July 2022
- Published by PANORAMA Publishing House
- No. 7,p. 64-65
Determination of the efficacy of oncolytic viruses in combination with autophagy inducers to potentize cancer cell death
Purpose of the study: to determine and analyze the possibility of potentiation of virotherapy by combination with autophagy inducers.
- 1 July 2022
- Published by PANORAMA Publishing House
- No. 7,p. 64-65
Determination of the efficacy of oncolytic viruses in combination with autophagy inducers to potentize cancer cell death
Purpose of the study: to determine and analyze the possibility of potentiation of virotherapy by combination with autophagy inducers.